Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Childhood overweight, tallness and growth increase risks of ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Determinants for participation in human papillomavirus self-sampling among non-attenders to cervical cancer screening in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prognostic Significance of HPV and p16 Status in Men Diagnosed with Penile Cancer: A Systematic Review and Meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  1. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Correction: Educational delay and attainment in persons with neurofibromatosis 1 in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  • E Susan Amirian
  • Quinn T Ostrom
  • Georgina N Armstrong
  • Rose K Lai
  • Xiangjun Gu
  • Daniel I Jacobs
  • Ali Jalali
  • Elizabeth B Claus
  • Jill S Barnholtz-Sloan
  • Dora Il'yasova
  • Joellen M Schildkraut
  • Francis Ali-Osman
  • Siegal Sadetzki
  • Robert B Jenkins
  • Daniel H Lachance
  • Sara H Olson
  • Jonine L Bernstein
  • Ryan T Merrell
  • Margaret R Wrensch
  • Christoffer Johansen
  • Richard S Houlston
  • Michael E Scheurer
  • Sanjay Shete
  • Christopher I Amos
  • Beatrice Melin
  • Melissa L Bondy
View graph of relations

BACKGROUND: There have been few studies of sufficient size to address the relationship between glioma risk and the use of aspirin or NSAIDs, and results have been conflicting. The purpose of this study was to examine the associations between glioma and aspirin/NSAID use, and to aggregate these findings with prior published studies using meta-analysis.

METHODS: The Glioma International Case-Control Study (GICC) consists of 4,533 glioma cases and 4,171 controls recruited from 2010 to 2013. Interviews were conducted using a standardized questionnaire to obtain information on aspirin/NSAID use. We examined history of regular use for ≥6 months and duration-response. Restricted maximum likelihood meta-regression models were used to aggregate site-specific estimates, and to combine GICC estimates with previously published studies.

RESULTS: A history of daily aspirin use for ≥6 months was associated with a 38% lower glioma risk, compared with not having a history of daily use [adjusted meta-OR = 0.62; 95% confidence interval (CI), 0.54-0.70]. There was a significant duration-response trend (P = 1.67 × 10-17), with lower ORs for increasing duration of aspirin use. Duration-response trends were not observed for NSAID use. In the meta-analysis aggregating GICC data with five previous studies, there was a marginally significant association between use of aspirin and glioma (mOR = 0.84; 95% CI, 0.70-1.02), but no association for NSAID use.

CONCLUSIONS: Our study suggests that aspirin may be associated with a reduced risk of glioma.

IMPACT: These results imply that aspirin use may be associated with decreased glioma risk. Further research examining the association between aspirin use and glioma risk is warranted.

Original languageEnglish
JournalCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Volume28
Issue number3
Pages (from-to)555-562
Number of pages8
ISSN1055-9965
DOIs
Publication statusPublished - Mar 2019

ID: 57384357